EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bridging Mammography and Lung Cancer Screening: Eligibility, Uptake and Potential Impact

Ali Ajrouch iD, Yara Khalifeh, Amir F Beirat, Dana Alhaffar, Ahmad Karkash, Razan Aljaras, Adel Hajj Ali, Nicholas Pettit iD, Deanna R Willis, Victoria L Champion, Lisa Carter-Bawa, Amrou Awaysheh iD und 1 weitere

Cancer Medicine · 2026

DOI: 10.1002/cam4.71528 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Ali Ajrouch und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Mammography, Lung Neoplasms, Early Detection of Cancer. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Lung cancer (LC) is the top cancer killer in women, yet lung cancer screening (LCS) uptake is substantially lower than mammography. Leveraging the reach of mammography programs may improve LCS uptake, but the potential gain in LC detection from this approach is unknown. This study aimed to determine the proportion of women with LC eligible for both screenings, potential LC detection via integrated screening, and factors influencing each screening uptake among those dually eligible.

Methods

This retrospective cross‐sectional study included 345 women newly diagnosed with LC presenting at a Midwestern Comprehensive Cancer Center (2019–2020). Pre‐diagnosis LCS‐eligibility was determined per 2013 and 2021 USPSTF criteria, LCS‐uptake per 2013 criteria, and mammography‐eligibility per 2016 criteria. We assessed sociodemographic variables associated with screening uptake among dually eligible women.

Results

Among 345 women (mean [SD] age 64.8 [11.35] years), 73.3% were eligible for mammography, while 43.5% were eligible for LCS (2013), increasing to 49.3% (2021). Mammography uptake (41.5%) substantially exceeded LCS uptake (13.9%). Overall, 45.2% were eligible for both screenings, representing 92.4% (157/170) of all LCS‐eligible (2021) cases. Notably, 20.3% were LCS‐eligible (2021) and received mammography, that is, 41.2% (70/170) of LCS‐eligible cases. Among dually eligible women, rural residency correlated with lower LCS uptake (odds ratio [OR], 0.42; 95% CI = 0.19–0.94; p = 0.031), whereas receiving mammography correlated with higher LCS uptake (OR, 2.67; 95% CI = 1.21–5.87; p = 0.013).

Conclusion

A substantial proportion of women with LC who are LCS‐eligible underwent mammography, representing a missed opportunity for earlier LC detection. Integrating these screenings could enhance LC detection, especially for rural residents who experience disparities in LCS but not mammography uptake.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MammographyLung NeoplasmsEarly Detection of CancerHumansFemaleRetrospective StudiesCross-Sectional StudiesMiddle AgedAgedMass Screening

Stichwörter der Autor:innen

health disparitieslung cancerlung cancer screeningmammographymarket viability assessmentwomen’s health

Autor:innen und Institutionen

  • Department of Family Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Internal Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • School of Nursing, Indiana University, Indianapolis, Indiana, USA.
  • Cancer Prevention Precision Control Institute, Center for Discovery & Innovation at Hackensack Meridian Health, Nutley, New Jersey, USA.
  • Cancer Prevention & Control Program, Georgetown Lombardi Comprehensive Cancer Center Consortium, Washington, DC, USA.

ORCID-Profile: Ali Ajrouch, Nicholas Pettit, Amrou Awaysheh

Zitieren

APA

Ajrouch, A., Khalifeh, Y., Beirat, A. F., Alhaffar, D., Karkash, A., Aljaras, R., Ali, A. H., Pettit, N., Willis, D. R., Champion, V. L., Carter-Bawa, L., Awaysheh, A., & Okuyemi, K. S. (2026). Bridging Mammography and Lung Cancer Screening: Eligibility, Uptake and Potential Impact. Cancer Medicine. https://doi.org/10.1002/cam4.71528

Vancouver

Ajrouch A, Khalifeh Y, Beirat AF, Alhaffar D, Karkash A, Aljaras R, et al. Bridging Mammography and Lung Cancer Screening: Eligibility, Uptake and Potential Impact. Cancer Medicine. 2026. doi:10.1002/cam4.71528

BibTeX
@article{Ajrouch2026,
  author = {Ajrouch, Ali and Khalifeh, Yara and Beirat, Amir F and Alhaffar, Dana and Karkash, Ahmad and Aljaras, Razan and Ali, Adel Hajj and Pettit, Nicholas and Willis, Deanna R and Champion, Victoria L and Carter-Bawa, Lisa and Awaysheh, Amrou and Okuyemi, Kolawole S},
  title = {Bridging Mammography and Lung Cancer Screening: Eligibility, Uptake and Potential Impact},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.71528}
}
Kostenlos starten →